{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:20:19Z","timestamp":1790360419667,"version":"4.1.0"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["834161"],"award-info":[{"award-number":["834161"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007384","name":"Instituto Nacional de Neuroci\u00eancia Translacional","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007384","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias Morfol\u00f3gicas"},{"name":"Coop\u00e9ration Universitaire et Scientifique avec le Br\u00e9sil"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-024-03318-x","type":"journal-article","created":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T11:02:16Z","timestamp":1738494136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["CCL21-CCR7 blockade prevents neuroinflammation and degeneration in Parkinson\u2019s disease models"],"prefix":"10.1186","volume":"22","author":[{"given":"Felipe Saceanu","family":"Leser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio de Souza","family":"J\u00fanyor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iohanna Bianca","family":"Pagnoncelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Beatriz","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Clara Campanelli","family":"N\u00f3brega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda da Silva","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiara Nascimento","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00edcolas Emanoel","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Boy\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Henrique Medeiros","family":"Geraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra Mendon\u00e7a Teles","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Maron-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Castro-Faria-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Follmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda Angela","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Eichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Ferreira","family":"Rom\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Regina Souza","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,2]]},"reference":[{"key":"3318_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, Luciano MS, Tanner C. The epidemiology of Parkinson\u2019s disease. Lancet. 2024;403:283\u201392.","journal-title":"Lancet"},{"key":"3318_CR2","first-page":"S21","volume":"54","author":"MC de Rijk","year":"2000","unstructured":"de Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Baldereschi M, et al. Prevalence of Parkinson\u2019s disease in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the Elderly Research Group. Neurology. 2000;54:S21\u20133.","journal-title":"Neurology"},{"key":"3318_CR3","first-page":"4","volume":"2017 18","author":"S Przedborski","year":"2017","unstructured":"Przedborski S. The two-century journey of Parkinson disease research. Nat Rev Neurosci. 2017;2017 18:4.","journal-title":"Nat Rev Neurosci"},{"key":"3318_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cger.2019.09.002","volume":"36","author":"J-A Palma","year":"2020","unstructured":"Palma J-A, Kaufmann H. Orthostatic Hypotension in Parkinson Disease. Clin Geriatr Med. 2020;36:53\u201367.","journal-title":"Clin Geriatr Med"},{"key":"3318_CR5","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1002\/mds.22589","volume":"24","author":"D Aarsland","year":"2009","unstructured":"Aarsland D, Marsh L, Schrag A. Neuropsychiatric symptoms in Parkinson\u2019s disease. Mov Disord. 2009;24:2175\u201386.","journal-title":"Mov Disord"},{"key":"3318_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/ana.21291","volume":"63","author":"GW Ross","year":"2008","unstructured":"Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, et al. Association of olfactory dysfunction with risk for future Parkinson\u2019s disease. Ann Neurol. 2008;63:167\u201373.","journal-title":"Ann Neurol"},{"key":"3318_CR7","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1126\/science.1098966","volume":"304","author":"J Greenamyre","year":"2004","unstructured":"Greenamyre J, Hastings T, Biomedicine. Parkinson\u2019s\u2014divergent causes, convergent mechanisms. Science. 2004;304:1120\u20132.","journal-title":"Science"},{"key":"3318_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22:657\u201373.","journal-title":"Nat Rev Immunol"},{"key":"3318_CR9","doi-asserted-by":"crossref","unstructured":"Roodveldt C, Bernardino L, Oztop-Cakmak O, Dragic M, Fladmark KE, Ertan S et al. The immune system in Parkinson\u2019s disease: what we know so far. Brain. 2024;awae177.","DOI":"10.1093\/brain\/awae177"},{"key":"3318_CR10","doi-asserted-by":"crossref","unstructured":"Masato A, Plotegher N, Boassa D, Bubacco L. Impaired dopamine metabolism in Parkinson\u2019s disease pathogenesis. Mol Neurodegeneration. 2019;14.","DOI":"10.1186\/s13024-019-0332-6"},{"key":"3318_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00401-006-0096-2","volume":"112","author":"JE Galvin","year":"2006","unstructured":"Galvin JE. Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson\u2019s disease: a case for the selective vulnerability of the substantia nigra. Acta Neuropathol. 2006;112:115\u201326.","journal-title":"Acta Neuropathol"},{"key":"3318_CR12","doi-asserted-by":"publisher","first-page":"27660","DOI":"10.1074\/jbc.M115.686584","volume":"290","author":"C Follmer","year":"2015","unstructured":"Follmer C, Coelho-Cerqueira E, Yatabe-Franco DY, Araujo T, Pinheiro GD, Domont AS. Oligomerization and membrane-binding Properties of Covalent Adducts formed by the Interaction of \u00ce\u00b1-Synuclein with the toxic dopamine metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL)*. J Biol Chem. 2015;290:27660\u201379.","journal-title":"J Biol Chem"},{"key":"3318_CR13","doi-asserted-by":"crossref","unstructured":"Masato A, Plotegher N, Terrin F, Sandre M, Faustini G, Thor A et al. DOPAL initiates \u03b1Synuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson\u2019s disease. Npj Parkinson\u2019s Disease. 2023;9.","DOI":"10.1038\/s41531-023-00485-1"},{"key":"3318_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neuropharm.2013.08.033","volume":"76","author":"TN Taylor","year":"2014","unstructured":"Taylor TN, Alter SP, Wang M, Goldstein DS, Miller GW. Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus. Neuropharmacology. 2014;76:97\u2013105. Pt A.","journal-title":"Neuropharmacology"},{"key":"3318_CR15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.neuro.2011.03.013","volume":"32","author":"LM Mexas","year":"2011","unstructured":"Mexas LM, Florang VR, Doorn JA. Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite. Neurotoxicology. 2011;32:471\u20137.","journal-title":"Neurotoxicology"},{"key":"3318_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0169-328X(01)00120-6","volume":"93","author":"SW Li","year":"2001","unstructured":"Li SW, Lin TS, Minteer S, Burke WJ. 3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson\u2019s disease pathogenesis. Mol Brain Res. 2001;93:1\u20137.","journal-title":"Mol Brain Res"},{"key":"3318_CR17","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0891-5849(01)00484-1","volume":"30","author":"BS Kristal","year":"2001","unstructured":"Kristal BS, Conway AD, Brown AM, Jain JC, Ulluci PA, Li SW, et al. Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria. Free Radic Biol Med. 2001;30:924\u201331.","journal-title":"Free Radic Biol Med"},{"key":"3318_CR18","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1111\/ejn.14764","volume":"53","author":"E Bagnoli","year":"2021","unstructured":"Bagnoli E, Diviney T, FitzGerald U. Dysregulation of astrocytic mitochondrial function following exposure to a dopamine metabolite: implications for Parkinson\u2019s disease. Eur J Neurosci. 2021;53:2960\u201372.","journal-title":"Eur J Neurosci"},{"key":"3318_CR19","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla LF, Song P, Mazzulli JR, Zampese E, Wong YC, Jeon S, et al. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science. 2017;357:1255\u201361.","journal-title":"Science"},{"key":"3318_CR20","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1172\/JCI72176","volume":"124","author":"G Liu","year":"2014","unstructured":"Liu G, Yu J, Ding J, Xie C, Sun L, Rudenko I, et al. Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation. J Clin Invest. 2014;124:3032\u201346.","journal-title":"J Clin Invest"},{"key":"3318_CR21","doi-asserted-by":"crossref","unstructured":"Mandel SA, Fishman T, Youdim MBH. Gene and protein signatures in sporadic Parkinson\u2019s disease and a novel genetic model of PD. Parkinsonism Relat Disorders. 2007;13.","DOI":"10.1016\/S1353-8020(08)70009-9"},{"key":"3318_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0378-4347(93)80310-Z","volume":"614","author":"MB Mattammal","year":"1993","unstructured":"Mattammal MB, Chung HD, Strong R, Hsu F-F. Confirmation of a dopamine metabolite in parkinsonian brain tissue by gas chromatography-mass spectrometry. J Chromatogr. 1993;614:205\u201312.","journal-title":"J Chromatogr"},{"key":"3318_CR23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1468-1331.2010.03246.x","volume":"18","author":"DS Goldstein","year":"2011","unstructured":"Goldstein DS, Sullivan P, Holmes C, Kopin IJ, Basile MJ, Mash DC. Catechols in post-mortem brain of patients with Parkinson disease. Eur J Neurol. 2011;18:703\u201310.","journal-title":"Eur J Neurol"},{"key":"3318_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00401-007-0303-9","volume":"115","author":"WJ Burke","year":"2008","unstructured":"Burke WJ, Kumar VB, Pandey N, Panneton \u00b7 W, Michael, Gan Q, Franko MW, et al. Aggregation of-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine. Acta Neuropathol. 2008;115:193\u2013203.","journal-title":"Acta Neuropathol"},{"key":"3318_CR25","doi-asserted-by":"crossref","unstructured":"Panneton WM, Kumar VB, Gan Q, Burke WJ, Galvin JE. The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis. PloS one [Internet]. 2010 [cited 2023 Jan 26];5. https:\/\/pubmed.ncbi.nlm.nih.gov\/21179455\/","DOI":"10.1371\/journal.pone.0015251"},{"key":"3318_CR26","doi-asserted-by":"crossref","unstructured":"Plotegher N, Berti G, Ferrari E, Tessari I, Zanetti M, Lunelli L et al. DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function. Scientific Reports [Internet]. 2017;7. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28084443\/","DOI":"10.1038\/srep40699"},{"key":"3318_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nri.2017.125","volume":"18","author":"Q Li","year":"2018","unstructured":"Li Q, Barres BA. Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol. 2018;18:225\u201342.","journal-title":"Nat Rev Immunol"},{"key":"3318_CR28","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nn.4222","volume":"19","author":"K Grabert","year":"2016","unstructured":"Grabert K, Michoel T, Karavolos MH, Clohisey S, Baillie JK, Stevens MP, et al. Microglial brain region\u2009\u2013\u2009dependent diversity and selective regional sensitivities to aging. Nat Neurosci. 2016;19:504\u201316.","journal-title":"Nat Neurosci"},{"key":"3318_CR29","doi-asserted-by":"publisher","first-page":"16603","DOI":"10.1073\/pnas.1903336116","volume":"116","author":"EB Miller","year":"2019","unstructured":"Miller EB, Zhang P, Ching K, Pugh EN, Burns ME. In vivo imaging reveals transient microglia recruitment and functional recovery of photoreceptor signaling after injury. Proc Natl Acad Sci USA. 2019;116:16603\u201312.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3318_CR30","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","volume":"19","author":"GW Kreutzberg","year":"1996","unstructured":"Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996;19:312\u20138.","journal-title":"Trends Neurosci"},{"key":"3318_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(01)05625-2","volume":"358","author":"A Cagnin","year":"2001","unstructured":"Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, et al. In-vivo measurement of activated microglia in dementia. Lancet. 2001;358:461\u20137.","journal-title":"Lancet"},{"key":"3318_CR32","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1146\/annurev-physiol-022516-034406","volume":"79","author":"SA Wolf","year":"2017","unstructured":"Wolf SA, Boddeke HWGM, Kettenmann H. Microglia in Physiology and Disease. Annu Rev Physiol. 2017;79:619\u201362.","journal-title":"Annu Rev Physiol"},{"key":"3318_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jneuroim.2008.04.012","volume":"198","author":"K Biber","year":"2008","unstructured":"Biber K, Vinet J, Boddeke HWGM. Neuron-microglia signaling: chemokines as versatile messengers. J Neuroimmunol. 2008;198:69\u201374.","journal-title":"J Neuroimmunol"},{"key":"3318_CR34","doi-asserted-by":"publisher","first-page":"8500","DOI":"10.1523\/JNEUROSCI.2451-04.2004","volume":"24","author":"A Rappert","year":"2004","unstructured":"Rappert A, Bechmann I, Pivneva T, Mahlo J, Biber K, Nolte C, et al. CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J Neurosci. 2004;24:8500\u20139.","journal-title":"J Neurosci"},{"key":"3318_CR35","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.4049\/jimmunol.168.3.1009","volume":"168","author":"S-C Chen","year":"2002","unstructured":"Chen S-C, Leach MW, Chen Y, Cai X-Y, Sullivan L, Wiekowski M, et al. Central nervous system inflammation and neurological disease in transgenic mice expressing the CC chemokine CCL21 in Oligodendrocytes. J Immunol. 2002;168:1009\u201317.","journal-title":"J Immunol"},{"key":"3318_CR36","doi-asserted-by":"publisher","first-page":"7548","DOI":"10.1523\/JNEUROSCI.1019-05.2005","volume":"25","author":"EK de Jong","year":"2005","unstructured":"de Jong EK, Dijkstra IM, Hensens M, Brouwer N, van Amerongen M, Liem RSB, et al. Vesicle-mediated transport and release of CCL21 in endangered neurons: a possible explanation for Microglia Activation Remote from a primary lesion. J Neurosci. 2005;25:7548\u201357.","journal-title":"J Neurosci"},{"key":"3318_CR37","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1172\/JCI19188","volume":"112","author":"JC Lo","year":"2003","unstructured":"Lo JC, Chin RK, Lee Y, Kang HS, Wang Y, Weinstock JV, et al. Differential regulation of CCL21 in lymphoid\/nonlymphoid tissues for effectively attracting T cells to peripheral tissues. J Clin Invest. 2003;112:1495.","journal-title":"J Clin Invest"},{"key":"3318_CR38","first-page":"5","volume":"8","author":"R F\u00f6rster","year":"2008","unstructured":"F\u00f6rster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Reviews Immunol 2008. 2008;8:5.","journal-title":"Nat Reviews Immunol 2008"},{"key":"3318_CR39","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1182\/blood-2003-11-3943","volume":"104","author":"N S\u00e1nchez-S\u00e1nchez","year":"2004","unstructured":"S\u00e1nchez-S\u00e1nchez N, Riol-Blanco L, De La Rosa G, Puig-Kr\u00f6ger A, Garc\u00eda-Bordas J, Mart\u00edn D, et al. Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood. 2004;104:619\u201325.","journal-title":"Blood"},{"key":"3318_CR40","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1126\/science.1228456","volume":"339","author":"M Weber","year":"2013","unstructured":"Weber M, Hauschild R, Schwarz J, Moussion C, de Vries I, Legler DF, et al. Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science. 2013;339:328\u201332.","journal-title":"Science"},{"key":"3318_CR41","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1084\/jem.20161864","volume":"214","author":"M Kozai","year":"2017","unstructured":"Kozai M, Kubo Y, Katakai T, Kondo H, Kiyonari H, Schaeuble K, et al. Essential role of CCL21 in establishment of central self-tolerance in T cells. J Exp Med. 2017;214:1925\u201335.","journal-title":"J Exp Med"},{"key":"3318_CR42","doi-asserted-by":"publisher","first-page":"eabe4601","DOI":"10.1126\/sciadv.abe4601","volume":"7","author":"S Da Mesquita","year":"2021","unstructured":"Da Mesquita S, Herz J, Wall M, Dykstra T, de Lima KA, Norris GT, et al. Aging-associated deficit in CCR7 is linked to worsened glymphatic function, cognition, neuroinflammation, and \u03b2-amyloid pathology. Sci Adv. 2021;7:eabe4601.","journal-title":"Sci Adv"},{"key":"3318_CR43","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1038\/sj.onc.1210114","volume":"26","author":"JD Shields","year":"2007","unstructured":"Shields JD, Emmett MS, Dunn DBA, Joory KD, Sage LM, Rigby H, et al. Chemokine-mediated migration of melanoma cells towards lymphatics\u2013a mechanism contributing to metastasis. Oncogene. 2007;26:2997\u20133005.","journal-title":"Oncogene"},{"key":"3318_CR44","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1593\/tlo.10178","volume":"3","author":"HD Cunningham","year":"2010","unstructured":"Cunningham HD, Shannon LA, Calloway PA, Fassold BC, Dunwiddie I, Vielhauer G, et al. Expression of the C-C chemokine receptor 7 mediates metastasis of breast cancer to the lymph nodes in mice. Translational Oncol. 2010;3:354\u201361.","journal-title":"Translational Oncol"},{"key":"3318_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00018-023-04788-7","volume":"80","author":"LH Geraldo","year":"2023","unstructured":"Geraldo LH, Garcia C, Xu Y, Leser FS, Grimaldi I, de Camargo Magalh\u00e3es ES, et al. CCL21-CCR7 signaling promotes microglia\/macrophage recruitment and chemotherapy resistance in glioblastoma. Cell Mol Life Sci. 2023;80:179.","journal-title":"Cell Mol Life Sci"},{"key":"3318_CR46","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1093\/infdis\/jiac313","volume":"226","author":"A Tveita","year":"2022","unstructured":"Tveita A, Murphy SL, Holter JC, Kildal AB, Michelsen AE, Lerum TV, et al. High circulating levels of the homeostatic chemokines CCL19 and CCL21 predict Mortality and Disease Severity in COVID-19. J Infect Dis. 2022;226:2150\u201360.","journal-title":"J Infect Dis"},{"key":"3318_CR47","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/glia.20426","volume":"54","author":"IM Dijkstra","year":"2006","unstructured":"Dijkstra IM, de Haas AH, Brouwer N, Boddeke HWGM, Biber K. Challenge with innate and protein antigens induces CCR7 expression by microglia in vitro and in vivo. Glia. 2006;54:861\u201372.","journal-title":"Glia"},{"key":"3318_CR48","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1002\/art.34452","volume":"64","author":"SR Pickens","year":"2012","unstructured":"Pickens SR, Chamberlain ND, Volin MV, Pope RM, Talarico NE, Mandelin AM, et al. Role of the CCL21 and CCR7 pathway in rheumatoid arthritis angiogenesis. Arthritis Rheum. 2012;64:2471.","journal-title":"Arthritis Rheum"},{"key":"3318_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-022-02640-6","volume":"19","author":"JD Cherry","year":"2022","unstructured":"Cherry JD, Baucom ZH, Eppich KG, Kirsch D, Dixon ER, Tripodis Y, et al. Neuroimmune proteins can differentiate between tauopathies. J Neuroinflamm. 2022;19:1\u201311.","journal-title":"J Neuroinflamm"},{"key":"3318_CR50","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00401-006-0083-7","volume":"112","author":"N Tanuma","year":"2006","unstructured":"Tanuma N, Sakuma H, Sasaki A, Matsumoto Y. Chemokine expression by astrocytes plays a role in microglia\/ macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis. Acta Neuropathol. 2006;112:195\u2013204.","journal-title":"Acta Neuropathol"},{"key":"3318_CR51","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1038\/emboj.2011.89","volume":"30","author":"K Biber","year":"2011","unstructured":"Biber K, Tsuda M, Tozaki-Saitoh H, Tsukamoto K, Toyomitsu E, Masuda T, et al. Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development. EMBO J. 2011;30:1864.","journal-title":"EMBO J"},{"issue":"1","key":"3318_CR52","first-page":"1","volume":"9","author":"S Noor","year":"2012","unstructured":"Noor S, Wilson EH. Role of C-C chemokine receptor type 7 and its ligands during neuroinflammation. J Neuroinflammation 2012. 2012;9(1):9:1\u20139.","journal-title":"J Neuroinflammation 2012"},{"key":"3318_CR53","doi-asserted-by":"publisher","first-page":"6797","DOI":"10.1523\/JNEUROSCI.3351-16.2017","volume":"37","author":"LP Diniz","year":"2017","unstructured":"Diniz LP, Tortelli V, Matias I, Morgado J, B\u00e9rgamo Araujo AP, Melo HM, et al. Astrocyte transforming growth factor Beta 1 protects synapses against A\u03b2 oligomers in Alzheimer\u2019s Disease Model. J Neurosci. 2017;37:6797\u2013809.","journal-title":"J Neurosci"},{"key":"3318_CR54","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0166-4328(94)90008-6","volume":"61","author":"P Simon","year":"1994","unstructured":"Simon P, Dupuis R, Costentin J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res. 1994;61:59\u201364.","journal-title":"Behav Brain Res"},{"key":"3318_CR55","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1212\/WNL.38.8.1237","volume":"38","author":"RL Doty","year":"1988","unstructured":"Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism. Neurology. 1988;38:1237\u20131237.","journal-title":"Neurology"},{"key":"3318_CR56","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/B978-0-444-63855-7.00024-1","volume":"164","author":"RD Prediger","year":"2019","unstructured":"Prediger RD, Schamne MG, Sampaio TB, Moreira ELG, Rial D. Animal models of olfactory dysfunction in neurodegenerative diseases. Handb Clin Neurol. 2019;164:431\u201352.","journal-title":"Handb Clin Neurol"},{"key":"3318_CR57","doi-asserted-by":"publisher","first-page":"9242","DOI":"10.1038\/s41598-020-66201-8","volume":"10","author":"ME Johnson","year":"2020","unstructured":"Johnson ME, Bergkvist L, Mercado G, Stetzik L, Meyerdirk L, Wolfrum E, et al. Deficits in olfactory sensitivity in a mouse model of Parkinson\u2019s disease revealed by plethysmography of odor-evoked sniffing. Sci Rep. 2020;10:9242.","journal-title":"Sci Rep"},{"key":"3318_CR58","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J","volume":"33","author":"N Stence","year":"2001","unstructured":"Stence N, Waite M, Dailey ME. Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices. Glia. 2001;33:256\u201366.","journal-title":"Glia"},{"key":"3318_CR59","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fncel.2018.00106","volume":"12","author":"S Heindl","year":"2018","unstructured":"Heindl S, Gesierich B, Benakis C, Llovera G, Duering M, Liesz A. Automated morphological analysis of microglia after stroke. Front Cell Neurosci. 2018;12:106.","journal-title":"Front Cell Neurosci"},{"key":"3318_CR60","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/nmeth.3125","volume":"11","author":"TA Ferreira","year":"2014","unstructured":"Ferreira TA, Blackman AV, Oyrer J, Jayabal S, Chung AJ, Watt AJ, et al. Neuronal morphometry directly from bitmap images. Nat Methods. 2014;11:982\u20134.","journal-title":"Nat Methods"},{"key":"3318_CR61","first-page":"57648","volume":"2018","author":"K Young","year":"2018","unstructured":"Young K, Morrison H. Quantifying Microglia morphology from photomicrographs of immunohistochemistry prepared tissue using ImageJ. J Visualized Experiments: JoVE. 2018;2018:57648.","journal-title":"J Visualized Experiments: JoVE"},{"key":"3318_CR62","doi-asserted-by":"crossref","unstructured":"Ippolito DM, Eroglu C. Quantifying synapses: an immunocytochemistry-based assay to quantify synapse number. J Vis Exp. 2010;2270.","DOI":"10.3791\/2270"},{"key":"3318_CR63","doi-asserted-by":"crossref","unstructured":"Ascoli GA, Krichmar JL, Nasuto SJ, Senft SL. Generation, description and storage of dendritic morphology data. K\u00f6tter R, editor. Phil Trans R Soc Lond B. 2001;356:1131\u201345.","DOI":"10.1098\/rstb.2001.0905"},{"key":"3318_CR64","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jneumeth.2010.12.011","volume":"195","author":"SK Schmitz","year":"2011","unstructured":"Schmitz SK, Hjorth JJJ, Joemai RMS, Wijntjes R, Eijgenraam S, de Bruijn P, et al. Automated analysis of neuronal morphology, synapse number and synaptic recruitment. J Neurosci Methods. 2011;195:185\u201393.","journal-title":"J Neurosci Methods"},{"key":"3318_CR65","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/bjc.1972.33","volume":"26","author":"JFR Kerr","year":"1972","unstructured":"Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a Basic Biological Phenomenon with Wideranging implications in tissue kinetics. Br J Cancer. 1972;26:239\u201357.","journal-title":"Br J Cancer"},{"key":"3318_CR66","doi-asserted-by":"publisher","first-page":"52ra73","DOI":"10.1126\/scitranslmed.3001059","volume":"2","author":"B Zheng","year":"2010","unstructured":"Zheng B, Liao Z, Locascio JJ, Lesniak KA, Roderick SS, Watt ML, et al. PGC-1\u03b1, a potential therapeutic target for early intervention in Parkinson\u2019s disease. Sci Transl Med. 2010;2:52ra73.","journal-title":"Sci Transl Med"},{"key":"3318_CR67","doi-asserted-by":"publisher","first-page":"10896","DOI":"10.1073\/pnas.95.18.10896","volume":"95","author":"JK Harrison","year":"1998","unstructured":"Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci U S A. 1998;95:10896\u2013901.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3318_CR68","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fnins.2020.00220","volume":"14","author":"TJ Petrisko","year":"2020","unstructured":"Petrisko TJ, Bloemer J, Pinky PD, Srinivas S, Heslin RT, Du Y, et al. Neuronal CXCL10\/CXCR3 Axis mediates the induction of cerebral hyperexcitability by peripheral viral challenge. Front Neurosci. 2020;14:220.","journal-title":"Front Neurosci"},{"key":"3318_CR69","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1046\/j.1460-9568.2003.02893.x","volume":"18","author":"G Banisadr","year":"2003","unstructured":"Banisadr G, Skrzydelski D, Kitabgi P, Rost\u00e8ne W, Parsadaniantz SM. Highly regionalized distribution of stromal cell-derived factor-1\/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur J Neurosci. 2003;18:1593\u2013606.","journal-title":"Eur J Neurosci"},{"key":"3318_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-020-0804-9","volume":"3","author":"A Keo","year":"2020","unstructured":"Keo A, Mahfouz A, Ingrassia AMT, Meneboo J-P, Villenet C, Mutez E, et al. Transcriptomic signatures of brain regional vulnerability to Parkinson\u2019s disease. Commun Biol. 2020;3:1\u201312.","journal-title":"Commun Biol"},{"key":"3318_CR71","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, De Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24:197\u2013211.","journal-title":"Neurobiol Aging"},{"key":"3318_CR72","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nature11405","volume":"489","author":"MJ Hawrylycz","year":"2012","unstructured":"Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, Shen EH, Ng L, Miller JA, et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature. 2012;489:391\u20139.","journal-title":"Nature"},{"key":"3318_CR73","doi-asserted-by":"publisher","first-page":"0984","DOI":"10.1371\/journal.pgen.0030098","volume":"3","author":"TG Lesnick","year":"2007","unstructured":"Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, De Andrade M, et al. A genomic pathway Approach to a Complex Disease: Axon Guidance and Parkinson Disease. PLoS Genet. 2007;3:0984\u201395.","journal-title":"PLoS Genet"},{"key":"3318_CR74","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.celrep.2020.01.010","volume":"30","author":"T Masuda","year":"2020","unstructured":"Masuda T, Sankowski R, Staszewski O, Prinz M. Microglia Heterogeneity in the single-cell era. Cell Rep. 2020;30:1271\u201381.","journal-title":"Cell Rep"},{"key":"3318_CR75","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3389\/fncel.2020.00198","volume":"14","author":"AM Jurga","year":"2020","unstructured":"Jurga AM, Paleczna M, Kuter KZ. Overview of General and discriminating markers of Differential Microglia phenotypes. Front Cell Neurosci. 2020;14:198.","journal-title":"Front Cell Neurosci"},{"key":"3318_CR76","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41583-018-0057-5","volume":"19","author":"O Butovsky","year":"2018","unstructured":"Butovsky O, Weiner HL. Microglial signatures and their role in health and disease. Nat Rev Neurosci. 2018;19:622\u201335.","journal-title":"Nat Rev Neurosci"},{"key":"3318_CR77","unstructured":"Documentation. Allen Human Brain Atlas - Gene List. https:\/\/help.brain-map.org\/display\/humanbrain\/Documentation. 2023. pp. 1\u201392."},{"key":"3318_CR78","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41582-019-0301-2","volume":"16","author":"E Tolosa","year":"2020","unstructured":"Tolosa E, Vila M, Klein C, Rascol O. LRRK2 in Parkinson disease: challenges of clinical trials. Nat Reviews Neurol. 2020;16:97\u2013107.","journal-title":"Nat Reviews Neurol"},{"key":"3318_CR79","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.tins.2021.12.002","volume":"45","author":"EM Rocha","year":"2022","unstructured":"Rocha EM, Keeney MT, Di Maio R, De Miranda BR, Greenamyre JT. LRRK2 and idiopathic Parkinson\u2019s disease. Trends Neurosci. 2022;45:224\u201336.","journal-title":"Trends Neurosci"},{"key":"3318_CR80","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.cell.2019.07.028","volume":"178","author":"K Jaeger","year":"2019","unstructured":"Jaeger K, Bruenle S, Weinert T, Guba W, Muehle J, Miyazaki T, et al. Structural basis for Allosteric Ligand Recognition in the human CC chemokine receptor 7. Cell. 2019;178:1222\u2013e123010.","journal-title":"Cell"},{"key":"3318_CR81","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1021\/ci200454v","volume":"52","author":"A Volkamer","year":"2012","unstructured":"Volkamer A, Kuhn D, Grombacher T, Rippmann F, Rarey M. Combining global and local measures for structure-based druggability predictions. J Chem Inf Model. 2012;52:360\u201372.","journal-title":"J Chem Inf Model"},{"key":"3318_CR82","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1021\/acs.jcim.3c00336","volume":"63","author":"J Graef","year":"2023","unstructured":"Graef J, Ehrt C, Rarey M. Binding site detection remastered: enabling fast, robust, and Reliable binding site detection and descriptor calculation with DoGSite3. J Chem Inf Model. 2023;63:3128\u201337.","journal-title":"J Chem Inf Model"},{"key":"3318_CR83","doi-asserted-by":"publisher","first-page":"19500","DOI":"10.1038\/s41598-019-55739-x","volume":"9","author":"P Sahbaie","year":"2019","unstructured":"Sahbaie P, Irvine K-A, Liang D-Y, Shi X, Clark JD. Mild traumatic brain Injury causes nociceptive sensitization through spinal chemokine upregulation. Sci Rep. 2019;9:19500.","journal-title":"Sci Rep"},{"key":"3318_CR84","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1158\/1535-7163.MCT-11-0915","volume":"11","author":"Y Ning","year":"2012","unstructured":"Ning Y, Labonte MJ, Zhang W, Bohanes PO, Gerger A, Yang D, et al. The CXCR2 antagonist, SCH-527123, shows Antitumor Activity and sensitizes cells to oxaliplatin in preclinical Colon Cancer models. Mol Cancer Ther. 2012;11:1353\u201364.","journal-title":"Mol Cancer Ther"},{"key":"3318_CR85","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1164\/rccm.201405-0992OC","volume":"191","author":"SI Rennard","year":"2015","unstructured":"Rennard SI, Dale DC, Donohue JF, Kanniess F, Magnussen H, Sutherland ER, et al. CXCR2 antagonist MK-7123. A phase 2 proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2015;191:1001\u201311.","journal-title":"Am J Respir Crit Care Med"},{"key":"3318_CR86","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/j.1365-2222.2012.04014.x","volume":"42","author":"P Nair","year":"2012","unstructured":"Nair P, Gaga M, Zervas E, Alagha K, Hargreave FE, O\u2019Byrne PM, et al. Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy. 2012;42:1097\u2013103.","journal-title":"Clin Exp Allergy"},{"key":"3318_CR87","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3390\/antiox9101007","volume":"9","author":"EM Prasad","year":"2020","unstructured":"Prasad EM, Hung S-Y. Behavioral tests in Neurotoxin-Induced Animal models of Parkinson\u2019s Disease. Antioxidants. 2020;9:1007.","journal-title":"Antioxidants"},{"key":"3318_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2010.03.004","volume":"211","author":"TN Taylor","year":"2010","unstructured":"Taylor TN, Greene JG, Miller GW. Behavioral phenotyping of mouse models of Parkinson\u2019s disease. Behav Brain Res. 2010;211:1\u201310.","journal-title":"Behav Brain Res"},{"key":"3318_CR89","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1212\/WNL.33.7.943","volume":"33","author":"CD Ward","year":"1983","unstructured":"Ward CD, Hess WA, Calne DB. Olfactory impairment in Parkinson\u2019s disease. Neurology. 1983;33:943\u20136.","journal-title":"Neurology"},{"key":"3318_CR90","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0006-8993(03)03354-7","volume":"989","author":"WJ Burke","year":"2003","unstructured":"Burke WJ, Li SW, Williams EA, Nonneman R, Zahm DS. 3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson\u2019s disease pathogenesis. Brain Res. 2003;989:205\u201313.","journal-title":"Brain Res"},{"key":"3318_CR91","doi-asserted-by":"publisher","first-page":"e23272","DOI":"10.1096\/fj.202301253R","volume":"37","author":"E Bagnoli","year":"2023","unstructured":"Bagnoli E, Trotier A, McMahon J, Quinlan LR, Biggs M, Pandit A, et al. Prodromal Parkinson\u2019s disease and the catecholaldehyde hypothesis: insight from olfactory bulb organotypic cultures. FASEB J. 2023;37:e23272.","journal-title":"FASEB J"},{"key":"3318_CR92","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.nbd.2011.12.040","volume":"46","author":"K McDowell","year":"2012","unstructured":"McDowell K, Chesselet M-F. Animal models of the non-motor features of Parkinson\u2019s disease. Neurobiol Dis. 2012;46:597\u2013606.","journal-title":"Neurobiol Dis"},{"key":"3318_CR93","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.nbd.2008.07.015","volume":"32","author":"MG Vuckovi\u0107","year":"2008","unstructured":"Vuckovi\u0107 MG, Wood RI, Holschneider DP, Abernathy A, Togasaki DM, Smith A, et al. Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. Neurobiol Dis. 2008;32:319\u201327.","journal-title":"Neurobiol Dis"},{"key":"3318_CR94","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/sj.mp.4001949","volume":"12","author":"HG Ruh\u00e9","year":"2007","unstructured":"Ruh\u00e9 HG, Mason NS, Schene AH. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry. 2007;12:331\u201359.","journal-title":"Mol Psychiatry"},{"key":"3318_CR95","doi-asserted-by":"crossref","unstructured":"Mathews TA, Fedele DE, Coppelli FM, Avila AM, Murphy DL, Andrews AM. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J Neurosci Methods. 2004. pp. 169\u201381.","DOI":"10.1016\/j.jneumeth.2004.05.017"},{"key":"3318_CR96","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1038\/s41380-022-01661-0","volume":"28","author":"J Moncrieff","year":"2023","unstructured":"Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry. 2023;28:3243\u201356.","journal-title":"Mol Psychiatry"},{"key":"3318_CR97","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AHV. Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol. 2006;5:235\u201345.","journal-title":"Lancet Neurol"},{"key":"3318_CR98","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1212\/WNL.45.9.1757","volume":"45","author":"RA Maricle","year":"1995","unstructured":"Maricle RA, Nutt JG, Valentine RJ, Carter JH. Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson\u2019s disease. Neurology. 1995;45:1757\u201360.","journal-title":"Neurology"},{"key":"3318_CR99","doi-asserted-by":"publisher","first-page":"8103","DOI":"10.1523\/JNEUROSCI.1495-09.2009","volume":"29","author":"TN Taylor","year":"2009","unstructured":"Taylor TN, Caudle WM, Shepherd KR, Noorian A, Jackson CR, Iuvone PM, et al. Nonmotor symptoms of Parkinson\u2019s Disease revealed in an animal model with reduced Monoamine Storage Capacity. J Neurosci. 2009;29:8103\u201313.","journal-title":"J Neurosci"},{"key":"3318_CR100","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.expneurol.2007.12.017","volume":"210","author":"S George","year":"2008","unstructured":"George S, van den Buuse M, San Mok S, Masters CL, Li QX, Culvenor JG. Alpha-synuclein transgenic mice exhibit reduced anxiety-like behaviour. Exp Neurol. 2008;210:788\u201392.","journal-title":"Exp Neurol"},{"key":"3318_CR101","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/ejn.12459","volume":"39","author":"SRW Stott","year":"2014","unstructured":"Stott SRW, Barker RA. Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson\u2019s disease. Eur J Neurosci. 2014;39:1042\u201356.","journal-title":"Eur J Neurosci"},{"key":"3318_CR102","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/0306-4522(95)00066-R","volume":"67","author":"S Przedborski","year":"1995","unstructured":"Przedborski S, Levivier M, Jiang H, Ferreira M, Jackson-Lewis V, Donaldson D, et al. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience. 1995;67:631\u201347.","journal-title":"Neuroscience"},{"key":"3318_CR103","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00702-004-0203-2","volume":"111","author":"A Storch","year":"2004","unstructured":"Storch A, Ludolph AC, Schwarz J. Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration. J Neural Transm (Vienna). 2004;111:1267\u201386.","journal-title":"J Neural Transm (Vienna)"},{"key":"3318_CR104","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0306-4522(02)00114-8","volume":"112","author":"K Biber","year":"2002","unstructured":"Biber K, Dijkstra I, Trebst C, De Groot CJA, Ransohoff RM, Boddeke HWGM. Functional expression of CXCR3 in cultured mouse and human astrocytes and microglia. Neuroscience. 2002;112:487\u201397.","journal-title":"Neuroscience"},{"key":"3318_CR105","doi-asserted-by":"crossref","unstructured":"Beamer CA, Shepherd DM. Inhibition of TLR ligand- and Interferon Gamma-Induced Murine Microglial activation by Panax Notoginseng. J Neuroimmune Pharmacol. 2012;7. https:\/\/doi.org\/10.1007\/s11481-011-9333\u20130.","DOI":"10.1007\/s11481-011-9333-0"},{"key":"3318_CR106","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.bbi.2009.04.007","volume":"24","author":"HRJ van Weering","year":"2010","unstructured":"van Weering HRJ, de Jong APH, de Haas AH, Biber KPH, Boddeke HWGM. CCL21-induced calcium transients and proliferation in primary mouse astrocytes: CXCR3-dependent and independent responses. Brain Behav Immun. 2010;24:768\u201375.","journal-title":"Brain Behav Immun"},{"key":"3318_CR107","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1172\/JCI66771","volume":"125","author":"M Krauthausen","year":"2015","unstructured":"Krauthausen M, Kummer MP, Zimmermann J, Reyes-Irisarri E, Terwel D, Bulic B, et al. CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer\u2019s disease model. J Clin Invest. 2015;125:365\u201378.","journal-title":"J Clin Invest"},{"key":"3318_CR108","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cell.2017.07.002","volume":"170","author":"XE Zhou","year":"2017","unstructured":"Zhou XE, He Y, de Waal PW, Gao X, Kang Y, Van Eps N, et al. Identification of Phosphorylation codes for Arrestin Recruitment by G protein-coupled receptors. Cell. 2017;170:457\u2013e46913.","journal-title":"Cell"},{"key":"3318_CR109","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.cell.2016.07.004","volume":"166","author":"ARB Thomsen","year":"2016","unstructured":"Thomsen ARB, Plouffe B, Cahill TJ, Shukla AK, Tarrasch JT, Dosey AM, et al. GPCR-G Protein-\u03b2-Arrestin Super-complex mediates sustained G protein signaling. Cell. 2016;166:907\u201319.","journal-title":"Cell"},{"key":"3318_CR110","doi-asserted-by":"publisher","first-page":"513747","DOI":"10.3389\/fimmu.2020.00528","volume":"11","author":"JL Rodr\u00edguez-Fern\u00e1ndez","year":"2020","unstructured":"Rodr\u00edguez-Fern\u00e1ndez JL, Criado-Garc\u00eda O. The chemokine receptor CCR7 uses distinct signaling modules with biased functionality to regulate dendritic cells. Front Immunol. 2020;11:513747.","journal-title":"Front Immunol"},{"key":"3318_CR111","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10637-023-01410-2","volume":"42","author":"AJ Armstrong","year":"2024","unstructured":"Armstrong AJ, Geva R, Chung HC, Lemech C, Miller WH Jr, Hansen AR, et al. CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial. Invest New Drugs. 2024;42:145\u201359.","journal-title":"Invest New Drugs"},{"key":"3318_CR112","doi-asserted-by":"crossref","unstructured":"Liang DY, Shi X, Liu P, Sun Y, Sahbaie P, Li WW et al. The chemokine receptor CXCR2 supports nociceptive sensitization after traumatic brain injury. Mol Pain. 2017;13.","DOI":"10.1177\/1744806917730212"},{"key":"3318_CR113","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1021\/acs.jcim.2c00803","volume":"62","author":"RP Sheridan","year":"2022","unstructured":"Sheridan RP. Stability of Prediction in Production ADMET models as a function of Version: why and when predictions change. J Chem Inf Model. 2022;62:3477\u201385.","journal-title":"J Chem Inf Model"},{"key":"3318_CR114","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1021\/acs.jcim.2c00699","volume":"62","author":"RP Sheridan","year":"2022","unstructured":"Sheridan RP, Culberson JC, Joshi E, Tudor M, Karnachi P. Prediction accuracy of production ADMET models as a function of Version: activity cliffs Rule. J Chem Inf Model. 2022;62:3275\u201380.","journal-title":"J Chem Inf Model"},{"key":"3318_CR115","doi-asserted-by":"publisher","unstructured":"Ferreira LLG, Andricopulo AD. ADMET modeling approaches in drug discovery. Drug Discovery Today [Internet]. 2019 [cited 2023 Sep 17];24. https:\/\/doi.org\/10.1016\/j.drudis.2019.03.015","DOI":"10.1016\/j.drudis.2019.03.015"},{"key":"3318_CR116","doi-asserted-by":"crossref","unstructured":"Ha H, Debnath B, Neamati N. Role of the CXCL8-CXCR1\/2 Axis in Cancer and Inflammatory Diseases. Theranostics [Internet]. 2017 [cited 2023 Sep 17];7. http:\/\/www.thno.org","DOI":"10.7150\/thno.15625"},{"key":"3318_CR117","doi-asserted-by":"publisher","first-page":"540878","DOI":"10.3389\/fneur.2020.540878","volume":"11","author":"M Serdar","year":"2020","unstructured":"Serdar M, Kempe K, Herrmann R, Picard D, Remke M, Herz J, et al. Involvement of CXCL1\/CXCR2 during Microglia Activation following inflammation-sensitized hypoxic-ischemic brain Injury in neonatal rats. Front Neurol. 2020;11:540878.","journal-title":"Front Neurol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-024-03318-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-024-03318-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-024-03318-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T11:02:26Z","timestamp":1738494146000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-024-03318-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,2]]},"references-count":117,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3318"],"URL":"https:\/\/doi.org\/10.1186\/s12974-024-03318-x","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,2]]},"assertion":[{"value":"13 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All in vivo experiments were conducted following the Brazilian Experimental Animal Use Guidelines. This study was approved by the Ethics Committee of the Health Sciences Center of the Federal University of Rio de Janeiro (UFRJ) (Protocol number A6\/19-001-16 and 025\/15).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}